Press Releases from Glioblastoma Multiforme Therapeutics (1 total)
Global Glioblastoma Multiforme Therapeutics Market to grow at a CAGR of 11.94 pe …
About Glioblastoma Multiforme
Glioblastoma multiforme is the most aggressive variant of malignant brain cancer. It has a poor prognosis with low rate of survival, a median of one year. The primary brain tumor happens due to uncontrolled cell division and developments in the brain. The tumors can be found in the glial cells or the neuron. The one which develops in the glial cells (astrocytes and oligodendrocytes) is called glioma, the…
